|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
|
Htg Molecular Diagnostics, Inc (HTGM) |
|
|
$0.28 0.00 (0.00%) as of 4:30 Fri 11/20
|
|
Download |
|
| |
Company
Roster
|
|
Total
Insiders : |
22 |
|
|
|
Total
Direct Shares :
|
4,471,592 |
|
|
Total
Indirect Shares :
|
2,174,391 |
| |
%
Held by Insiders:
|
49.68% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Barat Stephen |
Senior VP of Therapeutics |
2023-06-08 |
421 |
|
0 |
| Mcmeans Shaun D |
SVP, Finance & Admin. & CFO |
2022-12-09 |
10,570 |
2015-08-12 |
0 |
| Godlewski Laura Lee |
SVP Finance & Administration |
2022-12-09 |
4,904 |
|
0 |
| Lawson Byron |
SVP/Chief Commercial Officer |
2022-12-09 |
6,033 |
|
0 |
| Lubniewski John L |
President & CEO, Director |
2022-12-09 |
14,133 |
2015-05-11 |
0 |
| L5 Capital Inc. |
10% Owner |
2022-07-15 |
1,170,000 |
|
0 |
| Johnson Tim B |
Executive Chairman, Director |
2020-12-10 |
16,847 |
2015-08-12 |
0 |
| Lytton Laurence W |
10% Owner |
2020-02-25 |
2,297,173 |
2019-09-20 |
400,123 |
| George Harry A. |
Director |
2019-08-14 |
39,030 |
2019-08-14 |
144,366 |
| Hanham Ann |
Director |
2019-08-14 |
7,304 |
2018-08-15 |
0 |
| Burris Michelle |
Director |
2019-08-14 |
2,500 |
2019-08-14 |
0 |
| Mccracken Lee R. |
Director |
2019-08-14 |
5,000 |
2018-08-15 |
0 |
| Lafrance James T |
Director |
2019-08-14 |
12,500 |
2017-08-23 |
0 |
| Hardison Don M |
Director |
2019-08-14 |
12,500 |
2017-08-23 |
0 |
| Roche Patrick C. |
SVP Medical/Scientific Affairs |
2018-06-08 |
43,421 |
2015-08-18 |
0 |
| Gordon Debra A |
SVP, Chief Legal Counsel |
2018-01-29 |
72,552 |
2015-08-24 |
0 |
| Novo A/s |
10% Owner |
2017-08-25 |
0 |
2015-05-11 |
0 |
| Glaxosmithkline Plc |
Former 10% Owner |
2015-05-11 |
0 |
2017-03-27 |
792,781 |
| Senour Lawrence D. |
10% Owner |
2015-05-11 |
756,704 |
2015-05-11 |
0 |
| Qiagen Nv |
10% Owner |
|
0 |
2016-11-17 |
833,333 |
| Grimm Donald W |
Director |
|
0 |
2015-05-11 |
3,788 |
| Fsv Ii-B Lp |
|
|
0 |
|
0 |
|
|
